Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Page 1
Guideline implementation, drug sequencing, and quality of care in heart failure: design and rationale of TITRATE-HF.
Clephas PRD, Malgie J, Schaap J, Koudstaal S, Emans M, Linssen GCM, de Boer GA, van Heerebeek L, Borleffs CJW, Manintveld OC, van Empel V, van Wijk S, van den Heuvel M, da Fonseca C, Damman K, van Ramshorst J, van Kimmenade R, van de Ven ART, Tio RA, van Veghel D, Asselbergs FW, de Boer RA, van der Meer P, Greene SJ, Brunner-La Rocca HP, Brugts JJ. Clephas PRD, et al. Among authors: borleffs cjw. ESC Heart Fail. 2024 Feb;11(1):550-559. doi: 10.1002/ehf2.14604. Epub 2023 Dec 8. ESC Heart Fail. 2024. PMID: 38064176 Free PMC article.
We present the design and rationale for the real-world TITRATE-HF study, which aims to assess sequencing strategies for GDMT initiation, dose titration patterns (order and speed), intolerance for GDMT, barriers for implementation, and long-term outcomes in patients with de …
We present the design and rationale for the real-world TITRATE-HF study, which aims to assess sequencing strategies for GDMT initiation, dos …
Remote haemodynamic monitoring of pulmonary artery pressures in patients with chronic heart failure (MONITOR-HF): a randomised clinical trial.
Brugts JJ, Radhoe SP, Clephas PRD, Aydin D, van Gent MWF, Szymanski MK, Rienstra M, van den Heuvel MH, da Fonseca CA, Linssen GCM, Borleffs CJW, Boersma E, Asselbergs FW, Mosterd A, Brunner-La Rocca HP, de Boer RA; MONITOR-HF investigators. Brugts JJ, et al. Among authors: borleffs cjw. Lancet. 2023 Jun 24;401(10394):2113-2123. doi: 10.1016/S0140-6736(23)00923-6. Epub 2023 May 20. Lancet. 2023. PMID: 37220768 Clinical Trial.
There is a clear need for randomised trial data from patients treated with contemporary guideline-directed-medical-therapy with long-term follow-up in a different health-care system. METHODS: MONITOR-HF was an open-label, randomised trial, done in 25 centres in the Netherl …
There is a clear need for randomised trial data from patients treated with contemporary guideline-directed-medical-therapy with long-term …
Short-term career perspectives of young cardiologists in the Netherlands.
Vis JC, Borleffs CJ, Zwart B, Nuis RJ, Scherptong RWC. Vis JC, et al. Among authors: borleffs cj. Neth Heart J. 2017 Jul;25(7-8):455-460. doi: 10.1007/s12471-017-0971-6. Neth Heart J. 2017. PMID: 28236041 Free PMC article.
However, the number of permanent positions for young cardiologists did not follow that trend leading to concerns about future employment. Therefore, the aim of the current study was to assess short-term career perspectives of young cardiologists in the Netherlands. ...Furt …
However, the number of permanent positions for young cardiologists did not follow that trend leading to concerns about future employment. Th …
The clinical course of patients with implantable cardioverter-defibrillators: Extended experience on clinical outcome, device replacements, and device-related complications.
van der Heijden AC, Borleffs CJ, Buiten MS, Thijssen J, van Rees JB, Cannegieter SC, Schalij MJ, van Erven L. van der Heijden AC, et al. Among authors: borleffs cj. Heart Rhythm. 2015 Jun;12(6):1169-76. doi: 10.1016/j.hrthm.2015.02.035. Epub 2015 Mar 4. Heart Rhythm. 2015. PMID: 25749138
BACKGROUND: Large randomized trials demonstrated the beneficial effect of implantable cardioverter-defibrillator (ICD) and cardiac resynchronization therapy-defibrillator (CRT-D) treatments in selected patients. Data on long-term follow-up of patients outside the setting o …
BACKGROUND: Large randomized trials demonstrated the beneficial effect of implantable cardioverter-defibrillator (ICD) and cardiac resynchro …
Impact of clinical and echocardiographic response to cardiac resynchronization therapy on long-term survival.
Bertini M, Höke U, van Bommel RJ, Ng AC, Shanks M, Nucifora G, Auger D, Borleffs CJ, van Rijnsoever EP, van Erven L, Schalij MJ, Marsan NA, Bax JJ, Delgado V. Bertini M, et al. Among authors: borleffs cj. Eur Heart J Cardiovasc Imaging. 2013 Aug;14(8):774-81. doi: 10.1093/ehjci/jes290. Epub 2012 Dec 7. Eur Heart J Cardiovasc Imaging. 2013. PMID: 23221312
BACKGROUND: Clinical or echocardiographic mid-term responses to cardiac resynchronization therapy (CRT) may have a different influence on a long-term prognosis of heart failure patients treated with CRT. ...CONCLUSION: In a large population of heart failure patients …
BACKGROUND: Clinical or echocardiographic mid-term responses to cardiac resynchronization therapy (CRT) may have a different influenc …
Update on small-diameter implantable cardioverter-defibrillator leads performance.
van Rees JB, van Welsenes GH, Borleffs CJ, Thijssen J, van der Velde ET, van der Wall EE, van Erven L, Schalij MJ. van Rees JB, et al. Among authors: borleffs cj. Pacing Clin Electrophysiol. 2012 Jun;35(6):652-8. doi: 10.1111/j.1540-8159.2011.03338.x. Epub 2012 Feb 21. Pacing Clin Electrophysiol. 2012. PMID: 22352338
BACKGROUND: The performance of small diameter implantable cardioverter defibrillator (ICD) leads is questionable. However, data on performance during long-term follow-up are scarce. The aim of this study is to provide an update for the lead failure and cardiac perforation …
BACKGROUND: The performance of small diameter implantable cardioverter defibrillator (ICD) leads is questionable. However, data on performan …
Comparison of long-term survival of men versus women with heart failure treated with cardiac resynchronization therapy.
Mooyaart EA, Marsan NA, van Bommel RJ, Thijssen J, Borleffs CJ, Delgado V, van der Wall EE, Schalij MJ, Bax JJ. Mooyaart EA, et al. Among authors: borleffs cj. Am J Cardiol. 2011 Jul 1;108(1):63-8. doi: 10.1016/j.amjcard.2011.02.345. Epub 2011 Apr 27. Am J Cardiol. 2011. PMID: 21529733
Cox proportional hazard analysis revealed female gender is an independent predictor of long-term survival, together with heart failure etiology and renal function. In particular, women with heart failure due to a nonischemic etiology showed the best long-term surviv …
Cox proportional hazard analysis revealed female gender is an independent predictor of long-term survival, together with heart failur …
Impaired renal function is associated with echocardiographic nonresponse and poor prognosis after cardiac resynchronization therapy.
Van Bommel RJ, Mollema SA, Borleffs CJ, Bertini M, Ypenburg C, Marsan NA, Delgado V, Van Der Wall EE, Schalij MJ, Bax JJ. Van Bommel RJ, et al. Among authors: borleffs cj. J Am Coll Cardiol. 2011 Feb 1;57(5):549-55. doi: 10.1016/j.jacc.2010.06.060. J Am Coll Cardiol. 2011. PMID: 21272745 Free article.
Response to CRT was defined as a decrease in LV end-systolic volume 15% at 6-month follow-up. Primary end point during long-term follow-up was all-cause mortality. RESULTS: At baseline, mean estimated glomerular filtration rate (eGFR) was 70 28 ml/min/1.73 m2. ...Additiona …
Response to CRT was defined as a decrease in LV end-systolic volume 15% at 6-month follow-up. Primary end point during long-term foll …
Long-term follow-up of primary and secondary prevention implantable cardioverter defibrillator patients.
van Welsenes GH, van Rees JB, Borleffs CJ, Cannegieter SC, Bax JJ, van Erven L, Schalij MJ. van Welsenes GH, et al. Among authors: borleffs cj. Europace. 2011 Mar;13(3):389-94. doi: 10.1093/europace/euq494. Epub 2011 Jan 5. Europace. 2011. PMID: 21208947
However, data on potential differences between both groups in mortality and ICD therapy rates during long-term follow-up are scarce. The aim of the study was to assess differences in mortality and ICD therapy between secondary and primary prevention ICD recipients. ...A co …
However, data on potential differences between both groups in mortality and ICD therapy rates during long-term follow-up are scarce. …
Relative merits of left ventricular dyssynchrony, left ventricular lead position, and myocardial scar to predict long-term survival of ischemic heart failure patients undergoing cardiac resynchronization therapy.
Delgado V, van Bommel RJ, Bertini M, Borleffs CJ, Marsan NA, Arnold CT, Nucifora G, van de Veire NR, Ypenburg C, Boersma E, Holman ER, Schalij MJ, Bax JJ. Delgado V, et al. Among authors: borleffs cj. Circulation. 2011 Jan 4;123(1):70-8. doi: 10.1161/CIRCULATIONAHA.110.945345. Epub 2010 Dec 20. Circulation. 2011. PMID: 21173353
BACKGROUND: The relative merits of left ventricular (LV) dyssynchrony, LV lead position, and myocardial scar to predict long-term outcome after cardiac resynchronization therapy remain unknown and were evaluated in the present study. ...Larger baseline LV dyssynchrony pred …
BACKGROUND: The relative merits of left ventricular (LV) dyssynchrony, LV lead position, and myocardial scar to predict long-term out …
18 results